home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Stability Program to support Shipping and Distribution of Drug Products

 
  January 14, 2011  
     
 


ComplianceOnline, Online Event
2011-02-17


NOTE: Use This Promocode ( 117660 ) To Get 10% Discount. 

Why Should You Attend:

Drug Product must maintain its identity, strength, quality and purity throughout its expiration. Physical, chemical and biological data are influenced by various environmental factors such as temperature, humidity and light. In current manufacturing environment, products can be shipped and distributed across different climatic zones. Seasonal changes as well as types of transportation can greatly affect the supply chain of the products.

This webinar will outline stability studies to support shipping and distribution of drug products. Upon completion of this session, attendees will learn key factors that would affect the shipping and distribution of drug products. you will understand the product stability profile, typical environmental conditions for storage and anticipating environmental extremes for distribution. These data will be necessary to design shipping condition in order to maintain quality of the drug product through expiry.

Areas Covered in the Seminar:

  • Goal of stability studies.
  • Warning letters and observations on shipping and distribution practices.
  • Short term excursion study.
  • Thermal cycling study.
  • Analytical testing for these studies.

Who Will Benefit:

  • Pharmaceutical scientists
  • Manufacturers or raw material and ingredients
  • Analysts and lab managers
  • QA managers and personnel
  • Regulatory affairs

 

 
 
Organized by: ComplianceOnline
Invited Speakers: Kim Huynh-Ba , is the founder and Technical Director of Pharmalytik (www.pharmalytik.com). She has twenty two years of experience in various analytical areas of pharmaceutical development and a primary focus in stability sciences. Prior to Pharmalytik, she held positions in drug development at Astra Zeneca (formerly ICI Americas), DuPont Merck, DuPont Pharmaceuticals, Bristol Myers Squibb and Wyeth Vaccines. She has been advising pharmaceutical companies including companies operating under Consent Decree on harmonization and optimization of analytical best practices since 2001.
 
Deadline for Abstracts: 2011-02-17
 
Registration:

Attend Live Online Training

$295.00 One Dial-in One Attendee

$1,195.00 Group–Max. 10 Attendees 

 

 

E-mail: admin@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.